ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ORR Oriole Resources Plc

0.365
0.005 (1.39%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oriole Resources Plc LSE:ORR London Ordinary Share GB00B0T29327 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.005 1.39% 0.365 0.34 0.39 0.355 0.35 0.36 15,635,132 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Gold Ores 13k -2.22M -0.0011 -3.18 6.98M
Oriole Resources Plc is listed in the Gold Ores sector of the London Stock Exchange with ticker ORR. The last closing price for Oriole Resources was 0.36p. Over the last year, Oriole Resources shares have traded in a share price range of 0.0722p to 0.50p.

Oriole Resources currently has 1,994,021,336 shares in issue. The market capitalisation of Oriole Resources is £6.98 million. Oriole Resources has a price to earnings ratio (PE ratio) of -3.18.

Oriole Resources Share Discussion Threads

Showing 5101 to 5121 of 5200 messages
Chat Pages: 208  207  206  205  204  203  202  201  200  199  198  197  Older
DateSubjectAuthorDiscuss
22/5/2024
16:54
Good news and ends red, classic ORR
adi27
22/5/2024
11:55
rns today


Aptamer Group plc

("Aptamer", the "Company" or the "Group")

Aptamer and Timser partner to deliver world's first blood test for cervical cancer

Agreement for up to £465,000 signed for Optimer development

Optimer binders will be developed for use in a cervical cancer blood test



Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, has signed an agreement with Timser Group, a pharmaceutical company focused on women's health, with a deal value of up to £465,000.



Under the terms of the agreement, Aptamer Group will develop Optimer binders to Timser's patented cervical cancer biomarker panel - a three-protein signature that can be used to detect cervical cancer and precancerous lesions. The Optimers will power the world's first blood test for cervical cancer, preventing invasive smear tests and delivering earlier, more sensitive diagnostics.



Pairs of Optimer binders will be developed to each of the three biomarker proteins that form the unique cervical cancer signature. Timser will receive a licence for the use of the Optimers in its specific test combination, which is patented in 21 countries, including the USA.



Cervical cancer is the fourth most common cancer type in women worldwide. Present screening methods rely on invasive and relatively low sensitivity Papanicolaou (PAP) smear tests. The Optimer enabled Timser's diagnostic will allow earlier detection at the precancerous lesion stage, which is associated with increased survival. Use of a blood-based test over traditional PAP smears will offer the potential for increased detection rates by improving uptake due to the less invasive testing method.



As Timser expands its diagnostic tests into diverse markets, including low-income countries, the Optimer binders offer advantages to support continued supply and quality. With superior shelf-life and enhanced temperature stability compared to antibodies, Optimer binders facilitate global test distribution without compromising quality or performance. Previous attempts by Timser to develop antibodies to support the test have failed due to issues with antibody batch variability and supply chains. Unlike antibodies, Optimer binders are chemically manufactured, giving consistent quality, with the potential to use multiple manufacturers both locally and globally to prevent supply chain issues.





Dr Arron Tolley, Chief Technical Officer of Aptamer Group, said: "We are delighted to partner with Timser Group to facilitate their ground-breaking cancer diagnostic with Optimer binders. This deal demonstrates the increasing recognition of the Optimer platform to deliver high quality affinity ligands. We believe that implementing Optimer technology will allow our partners to overcome previous issues experienced with antibody variability and supply chains, and we look forward to delivering much-needed improvements to cervical cancer tests."

Mercedes Gutierrez, Chief Executive Officer of TIMSER Group: "We are equally excited about this collaboration with Aptamer Group. The potential of Optimer binders to enhance the accuracy and reliability of our cancer diagnostics tests is truly promising. By integrating this advanced technology, we are confident in our ability to overcome the limitations of traditional antibodies and improve the outcomes for patients undergoing cervical cancer screening. We look forward to a successful partnership and to witnessing the impact that this new technology will have for women across the globe."

citys2874
22/5/2024
11:53
ORR and RTOP having a good morning ready to breakout Hopefully later today
citys2874
22/5/2024
08:07
Try posting that over on the LSE forum.
luckyabbeygale
22/5/2024
08:03
Seems that they are trying to hide how bad the annual resort is in this sack of loss making death spiral pish.
terminator101
22/5/2024
07:53
More cash rolling into Oriole, another $300k from a legacy asset in Turkey.

The market value of ORR (£13m) is significantly out of kilter with prospects, discoveries, corporate activity not to mention the strong cash position.

Even at 1p a share the company would only be valued at £38m, not much if, as expected, they are sitting on a brand new gold trend in Cameroon.

Another GGP in the making - possibly!

observer007
21/5/2024
16:40
Can anyone please explain a theory regarding all the small trades over the last week or so. I'd like to believe the suggestion of African miners, but not convinced! lol.
adi27
21/5/2024
13:46
Landstead sells are only 2.4m on average a day.We are doing very well with the volumes these days and it is not a burden at all.1p + easily with the first drill news in a couple of weeks time.
dogsoggy36
21/5/2024
12:12
How do you know that they are Landstead sells?
abudhabi123
21/5/2024
11:30
Think you'll see 5p sooner than that. Another GGP in the making
jambam
21/5/2024
11:13
Lithium prospecting mentioned on the Twitter!
adi27
21/5/2024
08:32
im in for the long haul. going for 5p
vfleetsons@aol.com
20/5/2024
14:35
Price holding firm despite Landstead sells. This bodes very well.
logica2me
20/5/2024
09:44
I'm expecting an RNS this week. Someone knows something, based on the recent volumes.

0.4p is now a given, it's where we go from there that's exciting.

logica2me
20/5/2024
08:07
Gold on a charge, Oriole back in Cameroon this week, news imminent, a no brainer buy here if you can get any.

Multi bag opportunity.

one2go
17/5/2024
15:27
Looks like some serious news must be inbound, the shares traded above .50p recently, a stock like this could easily multi-bag, it looks like their large discoveries in Cameroon are starting to focus investors minds.

The former CEO suggested the gold trend in Cameroon could be an equal to that in Tanzania, just think about that for a moment and what it could to to the current £13m m/cap.

No wonder buyers are coming back.

goldenshread
17/5/2024
14:41
That would be incredible. Imagine...
logica2me
17/5/2024
14:14
Long term this will do a GGP style rise.
jambam
17/5/2024
13:34
1p all day long Dogsoggy
logica2me
17/5/2024
12:58
And on the first drill news.....This could easily do 100% in one day.
dogsoggy36
17/5/2024
12:46
We've absorbed the Landstead sells and the price has held well. Looking to crack 0.4o this afternoon then christ knows where the price will go. Probably 0.6p+
logica2me
Chat Pages: 208  207  206  205  204  203  202  201  200  199  198  197  Older

Your Recent History

Delayed Upgrade Clock